PALO ALTO, Calif.--(BUSINESS WIRE)--Robert Bosch Healthcare Systems, Inc. (Bosch Healthcare) announced today an agreement with Abbott's diabetes care business for a non-exclusive license under select Bosch Healthcare patents, for use in the diabetes field, following the termination of a previously established exclusive license agreement. As a result of these actions, Bosch Healthcare has reacquired sublicense rights under more than 150 issued patents and more than 40 patent applications for use in the diabetes field. These patents and patent applications are now available for licensing to healthcare companies focused on developing products and services for the management and/or monitoring of individuals with chronic medical conditions, including diabetes. The Bosch Healthcare patents include those which are directed at the collection of insulin dosage information, blood glucose readings and other laboratory data associated with diabetes management, monitoring and treatment.
According to Dr. Jasper zu Putlitz, M.D., president of Bosch Healthcare Systems, “Diabetes impacts millions of Americans, of all ages. The need to monitor and manage diabetes, and its symptoms continues to grow as does the need to prevent the complications of diabetes. Bosch Healthcare seeks to work with those companies that share our concern and are using innovation to help manage diabetes and other chronic medical conditions.”
Companies interested in establishing a licensing agreement under Bosch Healthcare patents should contact Greg Mathis.
About Robert Bosch Healthcare Systems, Inc.:
Robert Bosch Healthcare Systems, Inc., is a leading provider of innovative telehealth systems. Bosch’s product spectrum ranges from patient interfaces to comprehensive health management and patient evaluation software allowing healthcare professionals to efficiently evaluate the patient’s health status. Bosch Healthcare strives to help improve diagnosis and treatment through systematic patient monitoring and involvement. The result is that health professionals are able to provide a higher quality of care for patients with chronic conditions, patients lead happier and healthier lives, and the cost of healthcare is reduced for payers. Robert Bosch Healthcare Systems, Inc. is a fully owned subsidiary of the Bosch Group. For more information, go to www.bosch-telehealth.com.
In the U.S., Canada and Mexico, the Bosch Group manufactures and markets automotive original equipment and aftermarket solutions, industrial drives and control technology, power tools, security and communication systems, packaging technology, thermotechnology, household appliances, solar energy, healthcare telemedicine and software solutions. Having established a regional presence in 1906, Bosch employs nearly 24,600 associates in more than 100 locations, with consolidated sales of $10.6 billion in fiscal year 2012. For more information, visit www.boschusa.com, www.bosch.com.mx and www.bosch.ca.
The Bosch Group is a leading global supplier of technology and services. In fiscal 2012, its roughly 306,000 associates generated sales of $67.5 billion. Since the beginning of 2013, its operations have been divided into four business sectors: Automotive Technology, Industrial Technology, Consumer Goods, and Energy and Building Technology. The Bosch Group comprises Robert Bosch GmbH and its roughly 360 subsidiaries and regional companies in some 50 countries. If its sales and service partners are included, then Bosch is represented in roughly 150 countries. This worldwide development, manufacturing, and sales network is the foundation for further growth. Bosch spent some $6.1 billion for research and development in 2012, and applied for nearly 4,800 patents worldwide. The Bosch Group’s products and services are designed to fascinate, and to improve the quality of life by providing solutions which are both innovative and beneficial. In this way, the company offers technology worldwide that is “Invented for life.” Additional information is available online at www.bosch.com and www.bosch-press.com.